Barinthus Biotherapeutics plc (FRA:2AB)
Germany · Delayed Price · Currency is EUR 0.5850
0.00 (0.00%)
At close: Jan 29, 2026
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of €25.09 million as of January 30, 2026. Its market cap has decreased by -37.09% in one year.
Market Cap
25.09M
Enterprise Value
-27.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.59
Market Cap Chart
Since April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from 399.28M to 25.09M, a decrease of -93.72%. That is a compound annual growth rate of -44.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 25.09M | 3.05% |
| Dec 31, 2025 | 24.35M | -48.13% |
| Dec 31, 2024 | 46.94M | -63.54% |
| Dec 29, 2023 | 128.74M | 56.98% |
| Dec 30, 2022 | 82.01M | -75.93% |
| Dec 31, 2021 | 340.74M | -14.66% |
| Apr 30, 2021 | 399.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 36.86M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.08M |
| Biomark Diagnostics | 29.00M |
| Rubean AG | 27.29M |
| Hyrican Informationssysteme Aktiengesellschaft | 24.25M |